Hossam Nada

779 citations
46 papers · 454 indexed · h-index 12

Hossam Nada

35 papers receiving 450 citations

Peers

Hossam Nada
Comparison fields: 5 of 74
  • Organic Chemistry 158
  • Immunology and Allergy 31
  • Computational Theory and Mathematics 66
  • Pharmacology 64
  • Molecular Biology 235
Replace Mingsong Shi with:
Mingsong Shi China
Gurubasavaraja Swamy Purawarga Matada India
Jingkang Shen China
Carolyn A. Weigelt United States
John L. Gilmore United States
Nicole Caspers United States
Weixin Xu United States
Norbert Furtmann Germany
Timothy B. Durham United States
Alessia Graziano Italy
Hossam Nada relative to Mingsong Shi China Mingsong Shi's profile →
Citations per field
00.5×1.5×2.5×
Mingsong Shi · 1×
Citations per year

Countries citing papers authored by Hossam Nada

Since Specialization
Citations

This map shows the geographic impact of Hossam Nada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossam Nada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossam Nada more than expected).

Fields of papers citing papers by Hossam Nada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossam Nada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossam Nada. The network helps show where Hossam Nada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hossam Nada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hossam Nada Line = papers co-authored together Hossam Nada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20250
5 20250
6 20250
7 20251
8 20250
9 20250
10 20254
11 20241
12 202413
13 202448
14 20243
15 20234
16 20233
17 202313
18 20239
19 202126
20
INHIBITION STUDIES ON A PANEL OF HUMAN CARBONIC ANHYDRASES WITH N1-SUBSTITUTED SECONDARY SULFONAMIDES INCORPORATING THIAZOLINONE OR IMIDAZOLONE-INDOLE TAILS
20193

About Hossam Nada

Hossam Nada is a scholar working on Organic Chemistry, Oncology and Computational Theory and Mathematics, having authored 46 papers that have together received 454 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Computational Drug Discovery Methods (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Synthesis and Catalytic Reactions (4 papers), HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Enzyme function and inhibition (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Organic Chemistry (158 citations), Immunology and Allergy (31 citations) and Computational Theory and Mathematics (66 citations). Hossam Nada has collaborated with scholars based in South Korea, Egypt and United States. Frequent co-authors include Kyeong Lee, Ahmed Elkamhawy, Sung-Do Kim, Claudiu T. Supuran, Ae Nim Pae, Nicholas A. Meanwell, Yongseok Choi, Silvia Bua, Walaa R. Mahmoud and Alessio Nocentini.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026